术前CONUT评分是高危因素早期宫颈癌患者的预后因素
该回顾性研究纳入2004至2015年间698例接受手术及术后同步放化疗的早期宫颈癌伴高危因素患者,按术前CONUT评分分为低组(<3)和高组(≥3)。高CONUT组5年无病生存和总生存均显著更差,且CONUT评分是多因素分析中DFS和OS的独立预测因子。
要点
- 术前CONUT评分≥3与早期宫颈癌术后同步放化疗患者预后不良显著相关。
- 高CONUT评分是DFS和OS的独立预测因子,且与淋巴结转移、宫旁浸润相关。
- 高CONUT评分患者可考虑接受巩固化疗。
核心结论
- 术前高CONUT评分提示接受手术及术后同步放化疗的高危因素早期宫颈癌患者预后不良。
研究设计与样本
- 回顾性研究,纳入2004至2015年间698例接受手术及术后同步放化疗的早期宫颈癌伴高危因素患者。
- 术后放疗剂量为45-50.4 Gy,分25-28次,同步化疗方案包含顺铂或紫杉醇。
- 基于ROC分析将患者分为低CONUT组(<3)和高CONUT组(≥3)。
主要发现
- 471例(67.5%)患者归入低CONUT组。
- 低CONUT组5年无病生存和总生存均显著优于高CONUT组(p<0.001和p=0.001)。
- 高CONUT评分与淋巴结转移、宫旁浸润、较低BMI和较低PNI评分显著相关(p<0.05)。
- 多因素分析显示CONUT评分是DFS和OS的独立预测因子。
- 在高PNI评分组中,CONUT评分仍能有效分层DFS(P=0.001)。
关键数值与推荐
- CONUT评分分组界值为3,低组<3,高组≥3。
- 术后放疗处方剂量45-50.4 Gy,分25-28次。
- 同步化疗 regimen 包含顺铂或紫杉醇。
临床怎么用
- 术前CONUT评分可用于识别高危因素早期宫颈癌术后同步放化疗后预后不良的患者。
- 对高CONUT评分患者应考虑给予巩固化疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal of the study was to confirm whether preoperative controlling nutritional status (CONUT) was a prognostic factor in early-stage cervical cancer patients with high-risk factors after surgery and postoperative concurrent chemoradiotherapy (CCRT). METHODS: Between 2004 and 2015, a total of 698 patients who were treated with surgery and postoperative CCRT were included in this retrospective study. The prescribed dose for postoperative radiotherapy was 45-50.4 Gy in 25-28 fractions and the concurrent chemotherapy regimen contained cisplatin or paclitaxel. Based on the receiver operating characteristic (ROC) analysis, the patients were classified into low (<3) and high (≥3) CONUT groups. RESULTS: Of all study patients, 471 (67.5%) patients were included in the low CONUT group. The low CONUT group had significantly better 5-year disease-free survival (DFS) and overall survival (OS) than the high CONUT group (p<0.001 and p = 0.001, respectively). A high CONUT score was significantly associated with lymph node metastasis, parametrial invasion, and poorer nutritional status, including lower body mass index (BMI) and lower prognostic nutritional index (PNI) score (p<0.05, respectively). The CONUT score was an independent predictor of DFS and OS in multivariate analysis. Notably, the CONUT score still efficiently stratified DFS in the high PNI score group (P = 0.001). CONCLUSIONS: The preoperative high CONUT scores indicated poor prognosis for early-stage cervical cancer patients with high-risk factors treated with surgery and postoperative CCRT. In clinical practice, patients with high CONUT score should be considered to receive consolidation chemotherapy.
引用
- Zhang G, Zhang Y, He F, et al. Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors. Gynecol Oncol. 2021. PMID: 34148719. doi:10.1016/j.ygyno.2021.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。